Profusa (NVACW) Common Equity (2021 - 2026)
Profusa (NVACW) reported Common Equity of -$28.2 million for Q1 2026, up 76.87% on a YoY basis from -$15.9 million in Q1 2025, and down 5.78% quarter-over-quarter from -$26.7 million in Q4 2025.
Profusa (NVACW) Common Equity (2021 - 2026) Analysis & Trends
Profusa has reported Common Equity for 6 years, with the latest figure at -$28.2 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 76.87% year-over-year to -$28.2 million; the trailing twelve-month figure through Mar 2026 stood at -$28.2 million (up 76.87% YoY), and the FY2025 full-year result was -$26.7 million, up 77.64% from the prior year.
- Common Equity for Q1 2026 stood at -$28.2 million, down from -$26.7 million in the prior quarter.
- The five-year high for Common Equity was -$373856.0 in Q3 2022, with the low at -$124.2 million in Q2 2025.
- Historically, Common Equity has averaged -$54.2 million across 5 years, with a median of -$28.2 million in 2026.
- Annual changes were most pronounced in 2022 — Common Equity soared 89.52% — and 2023, when it slumped 17656.3%.
- Profusa's Common Equity stood at -$619476.0 in 2022, then tumbled by 17656.3% to -$110.0 million in 2023, then declined by 8.37% to -$119.2 million in 2024, then jumped by 77.64% to -$26.7 million in 2025, then declined by 5.78% to -$28.2 million in 2026.
- The last three Common Equity figures came in at -$28.2 million (Q1 2026), -$26.7 million (Q4 2025), and -$34.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Profusa | - | - | - | -28.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.20 Mn |
| Dec 31, 2025 | -26.66 Mn |
| Sep 30, 2025 | -33.96 Mn |
| Jun 30, 2025 | -124.18 Mn |
| Mar 31, 2025 | -121.92 Mn |
| Dec 31, 2024 | -119.21 Mn |
| Sep 30, 2024 | -116.96 Mn |
| Jun 30, 2024 | -114.47 Mn |
| Mar 31, 2024 | -112.06 Mn |
| Dec 31, 2023 | -110.00 Mn |
| Sep 30, 2023 | -3.48 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -619,476.00 |
| Sep 30, 2022 | -373,856.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -2.20 Mn |
| Dec 31, 2021 | -5.91 Mn |